Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma

March 09, 2023 at 07:53 AM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new report on Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), following the release of selected data from its human volunteer LPS challenge trial for lead molecule POLB 001.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/proactives-robin-davison-publishes-fresh-research-note-on-poolbeg-pharma-346100498

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	255.91	-2.60 (-1.01%)
AAPL	317.64	-2.33 (-0.73%)
AMD	491.27	+13.70 (2.87%)
BAC	62.69	+0.01 (0.02%)
GOOG	331.86	-3.45 (-1.03%)
META	617.06	+0.29 (0.05%)
MSFT	493.55	-6.15 (-1.23%)
NVDA	232.78	+2.42 (1.05%)
ORCL	168.21	+9.43 (5.94%)
TSLA	360.41	+6.33 (1.79%)

Symbol

Price

Change (%)

AMZN

255.91

-2.60 (-1.01%)

AAPL

317.64

-2.33 (-0.73%)

AMD

491.27

+13.70 (2.87%)

BAC

62.69

+0.01 (0.02%)

GOOG

331.86

-3.45 (-1.03%)

Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma

Contact Details

More News

Recent Quotes